On May 15, 2025, a jury returned a verdict finding Amgen Inc. (“Amgen”) liable for antitrust violations and awarding Regeneron Pharmaceuticals, ...

Amgen’s AMGN stock has declined 10.4% in the past three months. A lot of this price decline is related to the broader ...

Patients with asthma who did not persist with biologic treatment had more exacerbations and used more oral corticosteroids, ...

A sweeping executive order signed by U.S. President Donald Trump to slash domestic drug prices has drawn fierce opposition ...

The story of chronic itch and its impact on quality of life is one dermatologists have heard often. Until recently, treatment ...

Tourmaline Bio disclosed results for a potential rival to a Novo Nordisk drug. Elsewhere, data emerged for a psychedelic and CRISPR Therapeutics expanded its toolkit.